Search

everythinglearnresearchcommunity

for

Search:↓

Some women with PCOS have CYP21 mutations and IRS1 variants, but these genetic factors are not major contributors to PCOS.

The review found no clear link between vitamin D receptor gene variations and polycystic ovary syndrome.

PNU157706 reduced rat sperm movement and fertility without affecting offspring health.

Finasteride and flutamide both reduce hair growth, but finasteride has fewer side effects.

People who carry the 21-Hydroxylase Deficiency gene are not more likely to have excessive male hormone levels.

Androgen receptor signaling causes early aging of cells important for hair growth by damaging their DNA.

Finasteride doesn't affect hormone levels in normal men.

Lipocalin-2 levels are higher in women with PCOS and may indicate insulin resistance.

Women with PCOS have unhealthy changes in their cholesterol particles that are not related to their body weight.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.

Women with PCOS who had antiandrogenic treatment before pregnancy had fewer complications than those without treatment.

Certain SHBG gene variants, like rs727428, are linked to higher testosterone levels in women with PCOS.

Chemotherapy causes hair loss starting soon after treatment begins and recovers about 3 months after ending, while tamoxifen does not significantly affect hair growth.

A woman with cervical cancer had rare scalp metastasis causing a unique type of hair loss.

All treatments reduce hair growth; low dose flutamide most effective with fewer side effects.

A woman had both Graham Little-Piccardi-Lassueur syndrome, causing hair loss, and complete androgen insensitivity syndrome, making her genetically male but physically female. This suggests androgens don't affect the hair loss condition.

Finasteride reduces dihydrotestosterone, increases testosterone, and may treat hirsutism in women.

Chromium supplements don't improve insulin, hormone levels, or cholesterol in women with PCOS but raise testosterone levels.

Men with male pattern hair loss have different levels of certain hormones compared to men without hair loss.

Women with polycystic ovarian syndrome are more likely to have cervical insufficiency, especially South Asian and Black women.

The N363S gene variant does not cause higher adrenal androgen levels in women with polycystic ovary syndrome.

Aldactone was more effective in reducing hair growth in women with hirsutism than Diane, despite having less impact on hormone levels.

Women with PCOS in Sicily show different levels of metabolic problems depending on their PCOS type, with obesity and abnormal lipid profiles being common.

Dihydrotestosterone causes p27 protein breakdown in ovarian and breast cancer cells by binding with SKP2.

Cimetidine did not reduce hair growth in women with hirsutism.

The study suggests certain ACE gene variations are more common in women with PCOS and may be linked to increased insulin resistance.

Platelet-rich plasma may improve embryo genetics in IVF.

Isoallopregnanolone may be a safe and effective treatment for reducing tics in a mouse model of Tourette syndrome.

Oxidative stress, not insulin resistance, is significantly related to free androgen index in PCOS.

Changing the diagnosis criteria for PCOS might miss women at risk for related health issues.